JP2003506008A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506008A5 JP2003506008A5 JP2000589696A JP2000589696A JP2003506008A5 JP 2003506008 A5 JP2003506008 A5 JP 2003506008A5 JP 2000589696 A JP2000589696 A JP 2000589696A JP 2000589696 A JP2000589696 A JP 2000589696A JP 2003506008 A5 JP2003506008 A5 JP 2003506008A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- fusion polypeptide
- domain
- acid molecule
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11338798P | 1998-12-23 | 1998-12-23 | |
| US60/113,387 | 1998-12-23 | ||
| PCT/US1999/030900 WO2000037642A1 (en) | 1998-12-23 | 1999-12-23 | Method of enhancing the biological activity of ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003506008A JP2003506008A (ja) | 2003-02-18 |
| JP2003506008A5 true JP2003506008A5 (https=) | 2007-01-25 |
| JP4493854B2 JP4493854B2 (ja) | 2010-06-30 |
Family
ID=22349103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000589696A Expired - Lifetime JP4493854B2 (ja) | 1998-12-23 | 1999-12-23 | リガンドの生物学的活性を増強する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7008781B1 (https=) |
| EP (1) | EP1141294B1 (https=) |
| JP (1) | JP4493854B2 (https=) |
| AT (1) | ATE290089T1 (https=) |
| AU (1) | AU776393B2 (https=) |
| CA (1) | CA2354846A1 (https=) |
| DE (1) | DE69924009T2 (https=) |
| HK (1) | HK1040093B (https=) |
| IL (1) | IL143558A0 (https=) |
| NZ (1) | NZ512326A (https=) |
| PL (1) | PL199645B1 (https=) |
| WO (1) | WO2000037642A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9901428D0 (sv) * | 1999-04-21 | 1999-04-21 | Karolinska Innovations Ab | Amphibodies |
| WO2001047951A2 (en) * | 1999-12-23 | 2001-07-05 | An-Go-Gen Inc. | Angiopoietin analogs |
| PL366000A1 (en) | 2000-08-08 | 2005-01-24 | M.G.V.S.Ltd. | Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| US20030027751A1 (en) * | 2001-04-10 | 2003-02-06 | Genvec, Inc. | VEGF fusion proteins |
| WO2003034990A2 (en) | 2001-10-25 | 2003-05-01 | Regeneron Pharmaceuticals, Inc. | Angiopoietins and methods of use thereof |
| GB0201679D0 (en) * | 2002-01-25 | 2002-03-13 | Asterion Ltd | Polypeptide variants |
| US7081443B2 (en) * | 2002-05-21 | 2006-07-25 | Korea Advanced Institutes Of Science And Technology (Kaist) | Chimeric comp-ang1 molecule |
| US8298532B2 (en) | 2004-01-16 | 2012-10-30 | Regeneron Pharmaceuticals, Inc. | Fusion polypeptides capable of activating receptors |
| WO2008100288A2 (en) * | 2006-09-15 | 2008-08-21 | The Burnham Institute | High affinity ephb receptor binding compounds and methods of use thereof |
| ES2612258T3 (es) | 2006-10-27 | 2017-05-16 | Sunnybrook Health Sciences Center | Agonistas multiméricos de Tie 2 y usos de los mismos en la estimulación de la angiogénesis |
| EP2307456B1 (en) | 2008-06-27 | 2014-10-15 | Amgen Inc. | Ang-2 inhibition to treat multiple sclerosis |
| EP2714738B1 (en) | 2011-05-24 | 2018-10-10 | Zyngenia, Inc. | Multivalent and monovalent multispecific complexes and their uses |
| US10150800B2 (en) | 2013-03-15 | 2018-12-11 | Zyngenia, Inc. | EGFR-binding modular recognition domains |
| CA2909080C (en) | 2013-04-11 | 2022-07-26 | Sunnybrook Research Institute | Methods, uses and compositions of tie2 agonists |
| CA2928852A1 (en) | 2013-11-01 | 2015-05-07 | Regeneron Pharmaceuticals, Inc. | Angiopoietin-based interventions for treating cerebral malaria |
| ES2867249T3 (es) | 2015-11-06 | 2021-10-20 | Regeneron Pharma | Angiopoyetinas para usar en la promoción de la coagulación sanguínea y en el tratamiento de trastornos de la coagulación sanguínea |
| KR101685532B1 (ko) * | 2016-04-26 | 2016-12-13 | 한국프라임제약주식회사 | 혈관내피성장인자 수용체 융합단백질 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0547163B1 (en) * | 1990-08-29 | 2002-02-06 | Centre Hospitalier Regional De Nantes | Protein polyligands joined to a stable protein core |
| US5401650A (en) * | 1990-10-24 | 1995-03-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Cloning and expression of biologically active α-galactosidase A |
| JPH08505765A (ja) | 1992-11-13 | 1996-06-25 | アムジエン・インコーポレーテツド | Ｅｃｋ受容体リガンド |
| US5747033A (en) | 1993-10-28 | 1998-05-05 | Regeneron Pharmaceuticals, Inc. | Method of enhancing the biological activity of Eph family ligands |
| US5643755A (en) | 1994-10-07 | 1997-07-01 | Regeneron Pharmaceuticals Inc. | Nucleic acid encoding tie-2 ligand |
| US5879672A (en) | 1994-10-07 | 1999-03-09 | Regeneron Pharmaceuticals, Inc. | Tie-2 ligand 1 |
| ATE232901T1 (de) * | 1994-04-04 | 2003-03-15 | Regeneron Pharma | Biologisch aktive ligande der eph familie |
| US5650490A (en) | 1994-10-07 | 1997-07-22 | Regeneron Pharmaceuticals, Inc. | Tie-2 ligand 2 |
| US5814464A (en) | 1994-10-07 | 1998-09-29 | Regeneron Pharma | Nucleic acids encoding TIE-2 ligand-2 |
| JP4122056B2 (ja) | 1995-04-06 | 2008-07-23 | リジエネロン ファーマシューティカルズ，インコーポレイテッド | Ｔｉｅ−２リガンド、その作製方法および使用方法 |
| CA2222055A1 (en) * | 1995-05-23 | 1996-11-28 | Morphosys Gesellschaft Fur Proteinoptimierung Mbh | Multimeric proteins |
| WO1997015667A1 (en) | 1995-10-25 | 1997-05-01 | Regeneron Pharmaceuticals, Inc. | Biologically active eph family ligands |
| US6337387B1 (en) * | 1995-11-17 | 2002-01-08 | Asahi Kasei Kabushiki Kaisha | Differentiation-suppressive polypeptide |
| US5814478A (en) | 1995-12-15 | 1998-09-29 | Regeneron Pharmaceuticals, Inc. | Tyrosine kinase receptors and ligands |
| WO1997023639A1 (en) * | 1995-12-22 | 1997-07-03 | Toray Industries, Inc. | Process for producing biologically active fused proteins |
| US5851797A (en) | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
| IL127623A0 (en) | 1996-06-19 | 1999-10-28 | Regeneron Pharma | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| US6265564B1 (en) * | 1996-08-02 | 2001-07-24 | Regeneron Pharmaceuticals, Inc. | Expressed ligand-vascular intercellular signalling molecule |
-
1999
- 1999-12-23 IL IL14355899A patent/IL143558A0/xx not_active IP Right Cessation
- 1999-12-23 JP JP2000589696A patent/JP4493854B2/ja not_active Expired - Lifetime
- 1999-12-23 HK HK02101186.0A patent/HK1040093B/en not_active IP Right Cessation
- 1999-12-23 PL PL349158A patent/PL199645B1/pl unknown
- 1999-12-23 CA CA002354846A patent/CA2354846A1/en not_active Abandoned
- 1999-12-23 WO PCT/US1999/030900 patent/WO2000037642A1/en not_active Ceased
- 1999-12-23 US US09/868,677 patent/US7008781B1/en not_active Expired - Lifetime
- 1999-12-23 EP EP99968956A patent/EP1141294B1/en not_active Expired - Lifetime
- 1999-12-23 DE DE69924009T patent/DE69924009T2/de not_active Expired - Lifetime
- 1999-12-23 NZ NZ512326A patent/NZ512326A/en not_active IP Right Cessation
- 1999-12-23 AT AT99968956T patent/ATE290089T1/de active
- 1999-12-23 AU AU27147/00A patent/AU776393B2/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003506008A5 (https=) | ||
| NZ515913A (en) | Modified chimeric polypeptides with improved pharmacokinetic properties | |
| CA2502385A1 (en) | Il-1 receptor based antagonists and methods of making and using | |
| US5143844A (en) | Construction of an igg binding protein to facilitate downstream processing using protein engineering | |
| Berdichevsky et al. | Matrix-assisted refolding of single-chain Fv–cellulose binding domain fusion proteins | |
| ATE421977T1 (de) | Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie | |
| JP2002523036A5 (https=) | ||
| Nilsson et al. | Competitive elution of protein A fusion proteins allows specific recovery under mild conditions | |
| Nilsson et al. | Multiple affinity domains for the detection, purification and immobilization of recombinant proteins | |
| EP1806402A3 (en) | CTLA4/CD28 ligands and uses therefor | |
| CA2264191A1 (en) | Recombinant toxin fragments | |
| KR960704038A (ko) | 세포 표면 수용체 Hek와 결합하는 사이토킨(Cytokines That Bind the Cell Surface Receptor Hek) | |
| WO1999063088A3 (en) | Membrane-bound proteins and nucleic acids encoding the same | |
| CA2372511A1 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
| JP2022543960A5 (https=) | ||
| IL145676A (en) | Tumor necrosis factor homologs and nucleic acids encoding the same | |
| CA2636075A1 (en) | Chimaeric fusion protein with superior chaperone and folding activities | |
| WO2000068376B1 (en) | Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same | |
| JP2012525143A (ja) | 不溶性の組み換えタンパク質に対して溶解性を付与する新規な融合タグ | |
| CA2324513A1 (en) | Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production | |
| JP2003506093A5 (https=) | ||
| AU2890901A (en) | Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same | |
| JP2021523101A5 (https=) | ||
| WO2001029224A3 (en) | Granulocyte peptide homolog zgpa1 | |
| ES2080759T3 (es) | Produccion de proteinas o polipeptidos fusionados. |